Frank Gentile is the founder of Casma Therapeutics. Casma Therapeutics has raised $162M in total funding. Latest round: Grant. Based in Boston, United States.
Frank Gentile is the President and CEO of Casma Therapeutics, a biotechnology startup launched in May 2018 by Third Rock Ventures with $58.5 million in Series A funding. He has led the company since its inception, overseeing its growth from a Third Rock spinout to a firm that has raised over $162 million across multiple rounds including Series B and Series C.
Full founder directory · Investor directory · Company funding database · Fundraising library